paper-with-me

Papers

Equivariant 3D-Conditional Diffusion Models for Molecular Linker Design

2022-10-11 · Ilia Igashov, Hannes Stärk, Clément Vignac, Victor Garcia Satorras, Pascal Frossard, Max Welling, Michael Bronstein, Bruno Correia

Fragment-based drug discovery has been an effective paradigm in early-stage drug development. An open challenge in this area is designing linkers between disconnected molecular fragments of interest to obtain chemically-relevant candidate drug molecules. In this work, we propose DiffLinker, an E(3)-equivariant 3D-conditional diffusion model for molecular linker design. Given a set of disconnected fragments, our model places missing atoms in between and designs a molecule incorporating all the initial fragments. Unlike previous approaches that are only able to connect pairs of molecular fragments, our method can link an arbitrary number of fragments. Additionally, the model automatically determines the number of atoms in the linker and its attachment points to the input fragments. We demonstrate that DiffLinker outperforms other methods on the standard datasets generating more diverse and synthetically-accessible molecules. Besides, we experimentally test our method in real-world applications, showing that it can successfully generate valid linkers conditioned on target protein pockets.

📄 PDF Abstract BibTeX arXiv:2210.05274

Code (1)

igashov/difflinker 공식 구현 pytorch

Tasks

Drug Discoveryvalid

Methods 이 논문이 사용한 방법론

Test 설명 없음
Diffusion Diffusion models generate samples by gradually removing noise from a signal, and their training objective can be expressed as a reweighted variational lower-bound…

Similar Papers 제목 키워드 기반

3DLinker: An E(3) Equivariant Variational Autoencoder for Molecular Linker Design

2022-05-15 · Yinan Huang, Xingang Peng, Jianzhu Ma, Muhan Zhang

Deep learning has achieved tremendous success in designing novel chemical compounds with desirable pharmaceutical properties. In this work, we focus on a new type of drug design problem -- generating a small "linker" to …

Drug Design

LinkerNet: Fragment Poses and Linker Co-Design with 3D Equivariant Diffusion

2023-09-21 · NeurIPS 2023 11

Targeted protein degradation techniques, such as PROteolysis TArgeting Chimeras (PROTACs), have emerged as powerful tools for selectively removing disease-causing proteins. One challenging problem in this field is design…

HybridLinker: Topology-Guided Posterior Sampling for Enhanced Diversity and Validity in 3D Molecular Linker Generation

2025-02-24 · Minyeong Hwang, Ziseok Lee, Kwang-Soo Kim, KyungSu Kim 외

Linker generation is critical in drug discovery applications such as lead optimization and PROTAC design, where molecular fragments are assembled into diverse drug candidates via molecular linker. Existing methods fall i…

DiversityDrug Discovery

SynCoGen: Synthesizable 3D Molecule Generation via Joint Reaction and Coordinate Modeling

2025-07-16 · Andrei Rekesh, Miruna Cretu, Dmytro Shevchuk, Vignesh Ram Somnath 외 arxiv

Synthesizability remains a critical bottleneck in generative molecular design. While recent advances have addressed synthesizability in 2D graphs, extending these constraints to 3D for geometry-based conditional generati…

Drug Discovery

EquiFlow: Equivariant Conditional Flow Matching with Optimal Transport for 3D Molecular Conformation Prediction

2024-12-15 · Qingwen Tian, Yuxin Xu, Yixuan Yang, Zhen Wang 외

Molecular 3D conformations play a key role in determining how molecules interact with other molecules or protein surfaces. Recent deep learning advancements have improved conformation prediction, but slow training speeds…